New Years Rocket: NYKODE. 20% upside short-term. Nykode Therapeutics ASA, a clinical-stage biopharmaceutical company based in Oslo, Norway, specializes in developing novel immunotherapies, including vaccines for cancer and infectious diseases. Its leading product candidates are VB10.NEO, a cancer neoantigen vaccine in Phase I/IIa trials for variou